Trastuzumab deruxtecan in HER2-mutated metastatic non-small cell lung cancer (NSCLC): Interim results of DESTINY-Lung01 Meeting Abstract


Authors: Smit, E.; Nakagawa, K.; Nagasaka, M.; Felip, E.; Goto, Y.; Li, B.; Pacheco, J.; Murakami, H.; Barlesi, F.; Saltos, A.; Perol, M.; Udagawa, H.; Saxena, K.; Shiga, R.; Guevara, F.; Acharyya, S.; Shahidi, J.; Planchard, D.; Jänne, P.
Abstract Title: Trastuzumab deruxtecan in HER2-mutated metastatic non-small cell lung cancer (NSCLC): Interim results of DESTINY-Lung01
Meeting Title: 2020 World Conference on Lung Cancer
Keywords: trastuzumab deruxtecan; metastatic non-small cell lung cancer; her2-mutated
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 3 Suppl.
Meeting Dates: 2021 Jan 28-31
Meeting Location: Singapore
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-03-01
Start Page: S173
Language: English
ACCESSION: WOS:000631349600197
PROVIDER: wos
DOI: 10.1016/j.jtho.2021.01.248
Notes: Meeting Abstract: MA11.03 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bob Tingkan Li
    278 Li
Related MSK Work